The Valley Desk

NCT00723255 · Interventional trial

Bevacizumab and Temsirolimus in Treating Patients With Recurrent or Persistent Endometrial Cancer

Overall registry status Completed

Phase 2

Conditions Recurrent Endometrial Carcinoma

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov